Mankind Pharma said it has acquired a majority stake in Upakarma Ayurveda, engaged in developing, manufacturing and selling ayurvedic and herbal products for an undisclosed amount. The company’s decision to invest...
Lupin’s Brazil subsidiary acquires 9 brands from Bausch Health
Drug maker Lupin said that its wholly-owned subsidiary in Brazil, MedQuímica Indústria Farmacêutica (MedQuímica), has signed a definitive agreement to acquire all rights to nine medicines from BL Indústria Ótica Ltda...
Medley-Cipla deal talks called off over valuation issues
Medley Pharmaceuticals has called off its sale after talks with lead contender Cipla failed on a valuation mismatch and differences over some agreement terms, multiple people aware of the development said. This is the...
InvAscent picks minority stake in domestic ophthalmic formulation firm Sunways for Rs 120 crore
Life Sciences and healthcare-focused private equity firm InvAscent has picked up a minority stake in Sunways India by investing Rs 120 crore ($15 million) from its India Life Sciences Fund III (ILSF III). Sunways...
CCI clears Abu Dhabi Investment Authority’s minority stake buy in Intas Pharmaceuticals
Anti-trust regulator Competition Commission of India (CCI) cleared Platinum Owl’s acquisition of a minority stake in Intas Pharmaceuticals. The proposed transaction involves a secondary acquisition by Platinum Owl...
Ex-Blackstone India co-head Mathew Cyriac’s fund buys 80% stake in Accutest Research Laboratories
Florintree Advisors, an alternate investment firm set up by former Blackstone India co-head, Mathew Cyriac has picked up an 80% stake in Accutest Research Laboratories, one of India’s leading independent clinical...
Torrent Pharmaceuticals to acquire 100% of Curatio Healthcare for Rs 2,000 crores
Ahmedabad-based Torrent Pharmaceuticals Limited has entered into a definitive agreement to acquire 100% of skincare manufacturer Curatio Healthcare for Rs. 2,000 crores. Skincare product maker- Curatio has a strong...
Biocon sells 5.4% stake in arm Syngene International for Rs 1,220 cr
Drugmaker Biocon on Tuesday divested a 5.4 per cent stake in its research arm Syngene International for a little over Rs 1,220 crore through an open market transaction. According to bulk deal data available with the...
Fountainvest, TPG, Warburg among bidders for Carlyle’s Ambio stake – sources
Private equity firms Fountainvest Capital Partners, TPG and Warburg Pincus are among final-round bidders for Carlyle Group’s stake in AmbioPharm Inc, people with knowledge of the transaction told Reuters. Carlyle...
Piramal, Cadila among 32 companies in race to buy Sharon Bio-Medicine
Piramal Pharma, Cadila Pharmaceuticals, Shamrock Pharmachemi and ACG Associated Capsules are among the 32 entities in the fray to acquire Sharon Bio-Medicine, which is undergoing a second round of insolvency...
CCI clears deal involving Sekhmet Pharmaventures, Optimus Drugs
The Competition Commission of India approved the proposed deal involving Sekhmet Pharmaventures and Optimus Drugs Pvt Ltd. Under the transaction, Sekhmet would buy a majority shareholding in Optimus Drugs. The fair...
NCLT approves demerger of pharma business from Piramal Enterprises
The National Company Law Tribunal on Friday approved the demerger of Piramal Enterprises’ (PEL) pharma business and the simplification of the company’s corporate structure. The order paves the way towards creation of...
